Adocia SA/€ADOC
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Adocia SA
Adocia SA is a clinical-stage biotechnology company headquartered in Lyon, France, specializing in the development of innovative formulations of therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Founded in 2005 by Gérard Soula and his sons Olivier and Rémi, the company has developed a proprietary BioChaperone® technology platform designed to enhance the efficacy and safety of therapeutic proteins. Adocia's clinical pipeline includes products such as BioChaperone Lispro, an ultra-rapid insulin formulation, and BioChaperone Combo, a combination of basal and rapid-acting insulins. The company has established a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize its products in China and other Asian and Middle Eastern territories. (,)
Ticker
€ADOC
Sector
Primary listing
PAR
Employees
77
Headquarters
Website
Adocia SA Metrics
BasicAdvanced
€163M
-
-€0.60
0.31
-
Price and volume
Market cap
€163M
Beta
0.31
52-week high
€12.34
52-week low
€2.86
Average daily volume
41K
Financial strength
Current ratio
1.136
Quick ratio
1.095
Long term debt to equity
-1,163.857
Total debt to equity
-1,696.759
Interest coverage (TTM)
-10.91%
Profitability
EBITDA (TTM)
-7.592
Gross margin (TTM)
-56.00%
Net profit margin (TTM)
-75.42%
Operating margin (TTM)
-62.62%
Effective tax rate (TTM)
-10.87%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on assets (TTM)
-19.81%
Return on equity (TTM)
233.49%
Valuation
Price to revenue (TTM)
11.292
Price to book
-263.66
Price to tangible book (TTM)
-262.8
Price to free cash flow (TTM)
-9.793
Free cash flow yield (TTM)
-10.21%
Free cash flow per share (TTM)
-0.91
Growth
Revenue change (TTM)
258.42%
Earnings per share change (TTM)
-60.71%
3-year revenue growth (CAGR)
-2.62%
10-year revenue growth (CAGR)
-3.80%
3-year earnings per share growth (CAGR)
-17.73%
10-year earnings per share growth (CAGR)
-7.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Adocia SA stock?
Adocia SA (ADOC) has a market cap of €163M as of October 27, 2025.
What is the P/E ratio for Adocia SA stock?
The price to earnings (P/E) ratio for Adocia SA (ADOC) stock is 0 as of October 27, 2025.
Does Adocia SA stock pay dividends?
No, Adocia SA (ADOC) stock does not pay dividends to its shareholders as of October 27, 2025.
When is the next Adocia SA dividend payment date?
Adocia SA (ADOC) stock does not pay dividends to its shareholders.
What is the beta indicator for Adocia SA?
Adocia SA (ADOC) has a beta rating of 0.31. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.